| Product ID |
Product Name |
CAS# |
Purity |
| Y3295419 |
PARP11 inhibitor ITK7 |
2411890-36-1 |
99% |
| Y3290782 |
NSC243928 mesylate |
59988-01-1 |
99% |
| Y3264455 |
Ampreloxetine hydrochloride |
1227056-87-2 |
99% |
| Y3268183 |
GSK1820795A |
2650253-86-2 |
99% |
| Y3267864 |
Mal-PEG2-NHS |
329364-72-9 |
95% |
| Y3261402 |
Fequesetide |
476014-70-7 |
99% |
| Y3260783 |
Insulin ß Chain Peptide (15-23) |
247044-67-3 |
98% |
| Y3270894 |
SJM-3 |
1234977-97-9 |
97% |
| Y3267930 |
DOTATATE |
177943-88-3 |
99% |
| Y3287061 |
7-Aminomethyl-10-methyl-11-fluoro camptothecin |
2378616-23-8 |
99% |
| Y3264542 |
PNU-159682 carboxylic acid |
1204819-92-0 |
92% |
| Y3296931 |
(+)-Butin |
74628-42-5 |
98% |
| Y3297411 |
BRD9500 |
1630760-75-6 |
99% |
| Y3310509 |
MUC5AC motif peptide |
244049-41-0 |
98.79% |
| Y3288434 |
Coumberone |
878019-47-7 |
99% |
| Y3258758 |
RGLS4326 |
2229964-07-0 |
97.14% |
| Y3294775 |
Ezurpimtrostat hydrochloride |
1914148-73-4 |
98% |
| Y3288308 |
BPK-21 |
2305052-77-9 |
99% |
| Y3118040 |
KDM2B-IN-2 |
1965248-01-4 |
98% |
| Y3289463 |
BLK-IN-2 |
2694871-86-6 |
98% |
| Y3309734 |
PTP1B-IN-3 diammonium |
2702673-78-5 |
95% |
| Y3255308 |
Thalidomide-O-C6-NHBoc |
2509093-23-4 |
95.07% |
| Y3258300 |
VPC-18005 |
2242480-48-2 |
99.32% |
| Y3250779 |
Gly-7-MAD-MDCPT |
2378427-68-8 |
97.65% |
| Y3264343 |
1,1',1'',1'''-[1,4-Piperazinediylbis(2,1-ethanediylnitrilo)]tetrakis[2-dodecanol] |
1265904-26-4 |
98.0% |
| Y3311057 |
FTO-IN-8 |
2640366-38-5 |
98% |
| Y3285714 |
RECQL5-IN-1 |
2718170-45-5 |
98% |
| Y3268255 |
DBCO-PEG3-oxyamine |
2748394-67-2 |
98% |
| Y3258645 |
Avibactam sodium hydrate |
2938989-90-1 |
95% |
| Y3309104 |
ALR2-IN-1 |
2799695-54-6 |
95% |
| Y3286783 |
IDO1/TDO-IN-4 |
461424-21-5 |
99% |
| Y3255240 |
Sulfo-NHS-Acetate sodium |
221222-61-3 |
95% |
| Y3287025 |
Ac-PLVE-FMK |
2679825-26-2 |
98% |
| Y3270433 |
BAY-5000 |
2639435-48-4 |
99% |
| Y3260366 |
Mal-EGGGG-PEG8-amide-bis(deoxyglucitol) |
2360920-01-8 |
99.89% |
| Y3289184 |
AA-T3A-C12 |
2938207-23-7 |
98% |
| Y3261540 |
SR12418 |
1801185-08-9 |
99% |
| Y3307940 |
CPS2 |
2756741-90-7 |
99% |
| Y3270431 |
PI5P4Ka-IN-1 |
2428737-31-7 |
98.49% |
| Y3297942 |
GBT1118 |
1628799-51-8 |
99% |
| Y3289296 |
AKR1C3-IN-9 |
2924824-43-9 |
99% |
| Y3296368 |
PI3K/Akt/CREB activator 1 |
2708177-73-3 |
99% |
| Y3293207 |
MMP2-IN-1 |
2764598-01-6 |
99% |
| Y3260761 |
ASR-490 |
2690312-67-3 |
99.05% |
| Y3261133 |
PU-48 |
335394-78-0 |
99.34% |
| Y3269787 |
GDC-6036-NH |
2417918-80-8 |
98.06% |
| Y3258935 |
MC-Gly-Gly-Phe-Gly-(R)-Cyclopropane-Exatecan |
2414254-51-4 |
95.19% |
| Y3294199 |
LRRK2-IN-7 |
2307277-93-4 |
98% |
| Y3265247 |
PBD dimer-2 |
145325-57-1 |
98.03% |
| Y3290554 |
Cholesterol 24-hydroxylase-IN-1 |
1613480-70-8 |
99% |
| Y3288968 |
Gumelutamide |
1831085-48-3 |
98% |
| Y3317325 |
C-Type Natriuretic Peptide (CNP) (1-22), human TFA |
1966153-17-2 |
98% |
| Y3293866 |
Gemcitabine elaidate hydrochloride |
2918768-08-6 |
99% |
| Y3286316 |
Myosin V-IN-1 |
1259177-59-7 |
97% |
| Y3310763 |
TRPC6-IN-3 |
2311863-36-0 |
99% |
| Y3118052 |
BE1218 |
2893967-40-1 |
98% |
| Y3291824 |
RhoNox-1 |
1447815-38-4 |
98% |
| Y3265411 |
Vulolisib |
2390105-79-8 |
99.60% |
| Y3293692 |
JC2-11 |
937820-89-8 |
98% |
| Y3268208 |
MyD88-IN-1 |
2911609-80-6 |
99.95% |
| Y3292500 |
FITC-GW3965 |
2374144-23-5 |
98% |
| Y3308459 |
ccc_R08 |
2919019-72-8 |
98% |
| Y3289810 |
YCT529 |
2863670-67-9 |
98% |
| Y3293174 |
Bafrekalant |
2256770-44-0 |
99% |
| Y3261791 |
SG-094 |
2922283-37-0 |
95% |
| Y3297934 |
DIBAC-GGFG-NH2CH2-Dxd |
2758875-01-1 |
99% |
| Y3306974 |
1-(Naphthalen-2-yl)prop-2-en-1-ol |
76635-88-6 |
95% |
| Y3288112 |
Adhesamine |
462605-73-8 |
95% |
| Y3269942 |
VV116 |
2779498-79-0 |
99% |
| Y3266250 |
UBA5-IN-1 |
1831169-11-9 |
98% |
| Y3296494 |
STING agonist-7 |
2767442-46-4 |
97% |
| Y3294896 |
MPG peptides, Pß |
791642-10-9 |
98% |
| Y3267474 |
XIAP degrader-1 |
2803617-91-4 |
99% |
| Y3295833 |
6-O-Propynyl-2'-deoxyguanosine |
1640051-47-3 |
99% |
| Y3291417 |
FX-909 |
2924573-90-8 |
98% |
| Y3267399 |
SK-3-91 |
2769753-23-1 |
98% |
| Y3289479 |
BRD7586 |
895460-70-5 |
99% |
| Y3289421 |
KIF18A-IN-6 |
2914879-10-8 |
98% |
| Y3306922 |
MitoSOX Red |
1003197-00-9 |
95% |
| Y3271316 |
FBA-IN-1 |
2605897-57-0 |
98% |
| Y3291344 |
DB0662 |
2769753-51-5 |
99% |
| Y3298049 |
7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzofuran-3(2H)-one |
1628954-41-5 |
95% |
| Y3296546 |
PDC31 |
634586-40-6 |
99% |
| Y3289454 |
AVJ16 |
2775241-92-2 |
99% |
| Y3291888 |
LY1 |
2883813-32-7 |
98% |
| Y3285718 |
9-Amino-NeuAc |
153232-60-1 |
98% |
| Y3291274 |
SRI-42127 |
2727872-68-4 |
99% |
| Y3266989 |
Ac-Lys-Val-Cit-PABC-MMAE |
1650569-89-3 |
99% |
| Y3293734 |
Hetrombopag |
2114365-78-3 |
95% |
| Y3104720 |
(2-Cyclopropylpyrimidin-5-yl)methanamine |
1211533-28-6 |
95% |
| Y3294148 |
(S,R,S)-AHPC-3-methylbutanyl acetate-methanesulfonothioate-Me-C10-NH2 TFA |
2417370-89-7 |
95% |
| Y3289424 |
D75-4590 |
384376-42-5 |
99% |
| Y3104751 |
TBI-166 |
1353734-12-9 |
98.00% |
| Y3294739 |
NJH-2-057 |
2858812-70-9 |
98% |
| Y3288996 |
ANKRD22-IN-1 |
1107710-62-2 |
99% |
| Y3306127 |
4-Chloro-2-(methoxycarbonyl)benzoic acid |
1310531-95-3 |
97% |
| Y3104754 |
IMP2-IN-1 |
1480482-51-6 |
99% |
| Y3286483 |
BCPA |
547731-67-9 |
98% |
| Y3118068 |
MMV676584 |
750621-19-3 |
98% |
| Y3295383 |
Fludarabine-Cl |
2734853-80-4 |
98% |